PlainRecalls
FDA Drug Low Class III Terminated

Lotemax (loteprednol etabonate ophthalmic gel 0.5%), Sterile, Rx Only, 5 g box, Bausch & Lomb, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA, NDC 24208-503-07.

Reported: June 19, 2019 Initiated: June 17, 2019 #D-1396-2019

Product Description

Lotemax (loteprednol etabonate ophthalmic gel 0.5%), Sterile, Rx Only, 5 g box, Bausch & Lomb, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA, NDC 24208-503-07.

Reason for Recall

Failed Stability Specifications: Out of specification for viscosity.

Details

Recalling Firm
Bausch & Lomb
Units Affected
170832 bottles
Distribution
Nationwide in the U.S.
Location
Tampa, FL

Frequently Asked Questions

What product was recalled?
Lotemax (loteprednol etabonate ophthalmic gel 0.5%), Sterile, Rx Only, 5 g box, Bausch & Lomb, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA, NDC 24208-503-07.. Recalled by Bausch & Lomb. Units affected: 170832 bottles.
Why was this product recalled?
Failed Stability Specifications: Out of specification for viscosity.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 19, 2019. Severity: Low. Recall number: D-1396-2019.